News
Guggenheim’s Jason Cassorla gave Cigna’s outlook a caffeine jolt, raising the target price to $388 while maintaining a “Buy” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback